I. Le Clézio, A. Vigroux, J.-M. Escudier
FULL PAPER
MS (ESI) 1167.4 [M + K+]+, 1151.5 [M + Na]+. C59H65N4O13PSSi
(1129.30): calcd. C 60.86, H 5.53, N 4.78; found: C 60.75, H 5.53,
N 4.66.
H), 2.98 and 2.82 (m, JH,P = 15.3 and 23.0 Hz, 2 H, 7Јb-H), 2.64
(A part of an ABX system, J = 8.5, 1.8 and 14.2 Hz, 1 H, 2Јa-H),
2.47 (B part of an ABX system, J = 5.7, 14.2 and JH,P = 1.4 Hz, 1
H, 2Јa-H), 2.28 (m, 1 H, 2Јb-H), 2.01 (m, 1 H, 6Јb-H), 1.92 (brd,
6 H, Me), 1.87 (m, J = 3.3, 7.6 and 14.0 Hz, 1 H, 2Јb-H), 1.60 (m,
1 H, 6Јb-H) ppm. 13C NMR (100 MHz, CD3OD): δ = 166.3, 152.4,
137.8, 137.4, 112.2, 112.0, 89.2, 87.2, 86.2, 86.1, 85.4, 85.3, 79.8,
72.7, 62.5, 40.8, 39.4, 29.5, 28.5, 12.6, 12.5 ppm. 31P NMR
(81 MHz, CD3OD): δ = 20.1 ppm. MS (DCI/NH3): 606.2 [M +
NH4]+, 589.2 [M + H]+.
Data for 9: TLC, Rf (AcOEt/MeOH, 8:2) = 0.4. 1H NMR
(400 MHz, CD3OD): δ = 7.84 (m, J = 1.2 Hz, 1 H, 6a-H), 7.65 (m,
J = 1.2 Hz, 1 H, 6a-H), 6.40 (dd, J = 7.4 and 7.5 Hz, 1 H, 1Јb-H),
6.37 (dd, J = 5.7 and 8.6 Hz, 1 H, 1Јa-H), 5.20 (m, J = 1.9, 1.9,
Oxo-oxathiaphosphorinane Derivative (SC,SP)-6: Triethylamine
(80 µL, 0.58 mmol) was added under argon to compound 3
(200 mg, 0.14 mmol) dissolved in anhydrous DMF (20 mL). After
2 h of stirring at 95 °C, the reaction mixture was diluted with ethyl
acetate and washed with water and brine. The organic layer was
then dried with MgSO4 and the solvent was removed in vacuo to
provide compound 6 (160 mg, 100% yield). TLC, Rf (AcOEt) =
1
0.50. H NMR (400 MHz, CDCl3): δ = 9.85 and 9.43 (2ϫs, 2 H,
NH), 7.62–6.80 (m, 25 H, Ph, 6a-H and 6b-H), 6.61 (dd, J = 5.6
and 9.1 Hz, 1 H, 1Јb-H), 6.46 (dd, J = 5.0 and 9.4 Hz, 1 H, 1Јa-
H), 5.20 (dd, J = 5.0 and JH,P = 8.4 Hz, 1 H, 3Јa-H), 4.30 (d, J =
5.7 Hz, 1 H, 3Јb-H), 4.16 (m, 1 H, 4Јa-H), 3.75 (s, 6 H, MeO), 3.68
(d, J = 6.7 Hz, 1 H, 4Јb-H), 3.45 (m, J = 2.0 and 10.3 Hz, 1 H,
5Јa-H), 3.37 (m, 2 H, 5Јa-H and 5Јb-H), 2.89 (m, 1 H, 7Јb-H), 2.76
(m, 1 H, 7Јb-H), 2.68 (m, 1 H, 2Јa-H), 2.40 (m, 1 H, 2Јa-H), 2.31
(m, 1 H, 2Јb-H), 2.00 (m, 1 H, 6Јb-H), 1.95 (m, 1 H, 2Јb-H), 1.88
(s, 3 H, Me), 1.59 (m, 1 H, 6Јb-H), 1.36 (s, 3 H, Me), 1.04 (s, 9 H,
tBu) ppm. 13C NMR (100 MHz, CDCl3): δ = 164.2, 159.0, 151.1,
150.9, 144.2, 135.9, 135.8, 135.3, 133.4, 132.6, 130.5, 130.3, 130.2,
128.7, 127.5, 113.6, 112.3, 112.1, 88.9, 87.6, 85.2, 84.6, 83.3, 79.4,
74.9, 63.6, 55.4, 40.2, 38.8, 28.2, 27.4, 27.0, 19.2, 12.6, 11.6.) ppm.
31P NMR (81 MHz, CDCl3): δ = 15.4 ppm. MS (ESI): 1167.5 [M
+ K]+, 1151.6 [M + Na]+. C59H65N4O13PSSi (1129.30): calcd. C
60.86, H 5.53, N 4.78; found: C 60.71, H 5.61, N 4.92.
and 6.0 Hz, 1 H, 3Јa-H), 4.88 (m, J = 1.8, 6.0, and 7.8 Hz, JH,P
Ͻ
1 Hz, 1 H, 5Јb-H), 4.49 (m, J = 2.9, 3.0, and 6.0 Hz, 1 H, 3Јb-H),
4.31 (dd, J = 2.0 and 3.0 Hz, 1 H, 4Јa-H), 3.93 (m, J = 1.9, 2.9,
and JH,P = 5.7 Hz, 1 H, 4Јb-H), 3.83 (d, J = 3.0 Hz, 2 H, 5Јa-H),
3.24–3.10 (m, 2 H, 7Јb-H), 2.62 (A part of an ABX system, J =
1.9, 5.7 and 14.1 Hz, 1 H, 2Јa-H), 2.45 (B part of an ABX system,
J = 6.0, 8.6, 14.2 and JH,P = 1.5 Hz, 1 H, 2Јa-H), 2.24 (m, 2 H,
2Јb-H), 2.18 (m, 2 H, 6Јb-H), 1.90 and 1.89 (brd, 6 H, Me) ppm.
13C NMR (100 MHz, CD3OD): δ = 166.1, 153.1, 137.8, 137.2,
111.9, 111.7, 90.0, 86.9, 86.5, 86.0, 85.7, 83.1, 79.3, 73.2, 62.1, 40.5,
40.0, 29.5, 28.4, 12.5 ppm. 31P NMR (81 MHz, CD3OD): δ =
20.3 ppm. MS (DCI/NH3) 606.0 [M + NH4]+, 589.0 [M + H]+.
C22H29N4O11PS (588.52): calcd. C 44.90, H 4.97, N 9.52; found C
44.20, H 5.12, N 8.99.
Thio-dioxaphosphorinane, Oxo-oxathiaphosphorinane, and Oxo-
oxathiaphosphorinane Derivatives (SC,RP)-7, (SC,RP)-8, (SC,SP)-9:
Tetrabutylammonium fluoride (93 µL, 0.039 mmol) was added un-
der argon at room temperature to the dinucleotide 4 (or 5/6)
(30 mg, 0.026 mmol) in anhydrous THF (2 mL). After 15 min,
THF was removed under vacuum. The crude material was treated
with TFA 2%/CH2Cl2 for 5 min, dried under high vacuum. and
chromatographed on silica gel with ethyl acetate/methanol (0 to
20%) as eluent. Compounds 7 (or 8/9) were recovered in 72, 77
and 88% yields, respectively.
[1] P. Herdewijn, Liebigs Ann. 1996, 1337–1348.
[2] P. Herdewijn, Biochim. Biophys. Acta 1999, 1489, 167–179.
[3] M. Meldgaard, J. Wengel, J. Chem. Soc., Perkin Trans. 1 2000,
3539–3554.
[4] C. J. Leumann, Bioorg. Med. Chem. 2002, 10, 841–854.
[5] a) K. Seio, T. Wada, K. Sakamoto, S. Yokoyama, M. Sekine,
J. Org. Chem. 1998, 63, 1429–1443; b) K. Seio, T. Wada, M.
Sekine, Helv. Chim. Acta 2000, 83, 162–180; c) M. Sekine, O.
Kurasawa, K. Shohda, K. Seio, T. Wada, J. Org. Chem. 2000,
65, 3571–3578; d) M. Sekine, O. Kurasawa, K. Shohda, K.
Seio, T. Wada, J. Org. Chem. 2000, 65, 6515–6524; e) M. Sek-
ine, O. Kurasawa, K. Shohda, K. Seio, T. Wada, Eur. J. Org.
Chem. 2001, 1989–1999.
[6] a) A. M. Sørensen, P. Nielsen, Org. Lett. 2000, 2, 4217–4219;
b) A. M. Sørensen, K. E. Nielsen, B. Vogg, J. P. Jacobsen, P.
Nielsen, Tetrahedron 2001, 57, 10191–10201; c) P. Børsting, P.
Nielsen, Chem. Commun. 2002, 2140–2141; d) C. Kirchhoff, P.
Nielsen, Tetrahedron Lett. 2003, 44, 6475–6478; e) P. Børsting,
M. Freitag, P. Nielsen, Tetrahedron 2004, 60, 10955–10966; f)
P. B ørsting, K. E. Nielsen, P. Nielsen, Org. Biomol. Chem. 2005,
3, 2183–2190; g) P. K. Sharma, B. H. Mikkelsen, M. S. Chris-
tensen, K. E. Nielsen, C. Kirchhoff, S. L. Pedersen, A. M.
Sørensen, K. Østergaard, M. Petersen, P. Nielsen, Org. Biomol.
Chem. 2006, 4, 2433–2445.
Data for 7: TLC, Rf (AcOEt/MeOH, 8:2) = 0.4. 1H NMR
(400 MHz, CD3OD): δ = 7.84 (m, J = 1.1 Hz, 1 H, 6b-H), 7.68 (m,
J = 1.1 Hz, 1 H, 6a-H), 6.46 (dd, J = 6.2 and 8.0 Hz, 1 H, 1Јb-H),
6.38 (dd, J = 5.6 and 8.7 Hz, 1 H, 1Јa-H), 5.22 (m, J = 1.7, 1.7,
5.3, and JH,P = 5.9 Hz, 1 H, 3Јa-H), 4.88 (m, 1 H, 5Јb-H), 4.60 (m,
1 H, JH,P = 1.0 Hz, 7Јb-H), 4.50 (m, 1 H, 3Јb-H), 4.45 (m, JH,P
=
24 Hz, 1 H, 7Јb-H), 4.32 (m, 1 H, 4Јa-H), 3.93 (m, J = 1.8, 2.6,
and JH,P = 4.6 Hz, 1 H, 4Јb-H), 3.85 (d, J = 3.2 Hz, 2 H, 5Јa-H),
2.60 (A part of an ABX system, J = 5.2, 5.6 and 14.1 Hz, 1 H, 2Јa-
H), 2.45 (B part of an ABX system, J = 1.7, 8.7, 14.1 and JH,P
=
1.0 Hz, 1 H, 2Јa-H), 2.39 (m, 1 H, 6Јb-H), 2.24–2.20 (m, 2 H, 2Јb-
H), 1.98 (brd, 3 H, a-Me), 1.91 (brd, 3 H, b-Me), 1.88 (m, 1 H,
6Јb-H) ppm. 13C NMR (100 MHz, CD3OD): δ = 165.2, 151.3,
136.6, 136.0, 111.4, 110.7, 87.3, 87.4, 85.0, 84.7, 79.6, 79.3, 71.8,
68.0, 61.6, 39.4, 38.1, 27.7, 12.8, 11.5 ppm. 31P NMR (81 MHz,
CD3OD): δ = 61.5 ppm. MS (DCI/NH3): 606.0 [M + NH4]+, 589.0
[M + H]+. C22H29N4O11PS (588.52): calcd. C 44.90, H 4.97, N 9.52;
found: C 45.23, H 4.85, N 9.34.
[7] E. T. Kool, Chem. Rev. 1997, 97, 1473–1487.
[8] I. Le Clezio, J.-M. Escudier, A. Vigroux, Org. Lett. 2003, 5,
161–164.
[9] C. Dupouy, N. Iché-Tarrat, M.-P. Durrieu, F. Rodriguez, J.-
M. Escudier, A. Vigroux, Angew. Chem. 2006, 118, 3705–3709;
Angew. Chem. Int. Ed. 2006, 45, 3623–3627.
[10] I. Le Clezio, H. Gornitzka, J.-M. Escudier, A. Vigroux, J. Org.
Chem. 2005, 70, 1620–1629.
Data for 8: TLC, Rf (AcOEt/MeOH, 8:2) = 0.4. 1H NMR
(400 MHz, CD3OD): δ = 7.85 (m, J = 1.2 Hz, 1 H, 6b-H), 7.67 (m,
J = 1.2 Hz, 1 H, 6a-H), 6.42 (dd, J = 6.2 and 7.6 Hz, 1 H, 1Јb-H),
6.38 (dd, J = 5.7 and 8.5 Hz, 1 H, 1Јa-H), 5.22 (m, J = 1.7, 1.9,
and 5.8 Hz, 1 H, 3Јa-H), 4.89 (m, 1 H, 5Јb-H), 4.52 (m, 1 H, 3Јb-
H), 4.33 (dd, J = 3.0 and 5.4 Hz, 1 H, 4Јa-H), 3.95 (m, J = 1.9,
2.8, and JH,P = 5.0 Hz, 1 H, 4Јb-H), 3.84 (d, J = 3.0 Hz, 2 H, 5Јa-
[11] C. Dupouy, I. Le Clezio, P. Lavedan, H. Gornitzka, J.-M. Es-
cudier, A. Vigroux, Eur. J. Org. Chem. 2006, 24, 5515–5525.
[12] M. H. Caruthers, Acc. Chem. Res. 1991, 24, 278–284.
[13] R. G. Pearson, J. Am. Chem. Soc. 1963, 85, 3533–3539.
[14] D. G. Gorestein, 1984. Phosphorus P-31 NMR: Principles and
Applications, Academic Press, Orlando, FL.
1940
www.eurjoc.org
© 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2007, 1935–1941